Schedule 13G ownership disclosure
APPLIED THERAPEUTICS INC
COMMON STOCK · CUSIP: 03828A101
Event date: 2025-03-31
- Filing-level shares
- 10,380,590
- Percent of class
- 8.9%
- T. Rowe Price Investment Management, Inc.
Shares: 10,380,590 · Class: 8.9%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001897612-25-000121
- Form type
- SCHEDULE 13G
- Filer
- Applied Therapeutics, Inc.
- CIK
- CIK 1697532
- Filed
- May 07, 2025
- Reporting period
- Mar 31, 2025
- Description
- Schedule 13G beneficial ownership